*	OR T2 T3 T1
*	OR T4 T5 T8 T7 T6
R1	Subsumes Arg1:T2 Arg2:T4	
R2	Has_negation Arg1:T14 Arg2:T13	
*	OR T16 T17
R3	Has_value Arg1:T20 Arg2:T19	
R4	AND Arg1:T21 Arg2:T22	
*	OR T25 T24
R5	Has_value Arg1:T29 Arg2:T31	
R6	Has_value Arg1:T32 Arg2:T33	
R7	Has_qualifier Arg1:T36 Arg2:T38	
R8	Has_value Arg1:T36 Arg2:T37	
R9	Has_value Arg1:T34 Arg2:T35	
R10	Has_qualifier Arg1:T44 Arg2:T43	
R11	Has_qualifier Arg1:T45 Arg2:T46	
R12	Has_qualifier Arg1:T47 Arg2:T48	
*	OR T51 T50
*	OR T54 T53
R13	Subsumes Arg1:T54 Arg2:T55	
R14	Has_qualifier Arg1:T52 Arg2:T54	
R15	Has_qualifier Arg1:T58 Arg2:T59	
R16	Has_temporal Arg1:T58 Arg2:T57	
*	OR T61 T62
R17	Has_qualifier Arg1:T60 Arg2:T61	
R18	Has_mood Arg1:T65 Arg2:T66	
R19	AND Arg1:T64 Arg2:T65	
R20	Has_temporal Arg1:T65 Arg2:T67	
R21	Has_index Arg1:T72 Arg2:T71	
R22	Has_temporal Arg1:T69 Arg2:T72	
*	OR T73 T74
R23	AND Arg1:T75 Arg2:T73	
R24	AND Arg1:T75 Arg2:T76	
*	OR T79 T80
R25	Has_mood Arg1:T79 Arg2:T81	
R26	AND Arg1:T78 Arg2:T79	
R27	Has_mood Arg1:T86 Arg2:T87	
R28	Has_temporal Arg1:T86 Arg2:T85	
R29	AND Arg1:T88 Arg2:T86	
R30	Has_temporal Arg1:T84 Arg2:T89	
*	OR T90 T83
R31	Has_index Arg1:T91 Arg2:T92	
R32	Has_temporal Arg1:T90 Arg2:T91	
R33	Has_index Arg1:T70 Arg2:T71	
T1	Drug 29 48	systemic medication
T2	Drug 14 21;38 48	topical medication
T3	Device 52 70	mechanical devices
T4	Drug 136 160	topical immunomodulators
T5	Device 162 175	punctal plugs
T6	Drug 177 192	corticosteroids
T7	Drug 194 223	preservative artificial tears
T8	Device 225 239	contact lenses
T11	Person 253 260	females
T12	Observation 267 285	active sexual life
T13	Negation 294 297	not
T14	Procedure 304 324	contraceptive method
T15	Person 327 333	Female
T16	Condition 351 359	pregnant
T17	Condition 363 372	lactating
T18	Person 374 380	Female
T19	Value 397 405	positive
T20	Measurement 406 426	urine pregnancy test
T21	Condition 428 452	Positive drug addictions
T22	Procedure 455 475	verbal interrogatory
T23	Competing_trial 478 566	Subjects who have participated on any other research clinical trials on the last 40 days
T24	Condition 586 603	mentally disabled
T25	Condition 577 582;595 603	legal disabled
T26	Informed_consent 568 663	Subjects legal or mentally disabled to give an informed consent for participating on this study
T27	Non-query-able 665 748	Subjects who can't comply with the appointments or with every protocol requirement.
T28	Condition 750 788	Serious tear film dysfunction syndrome
T29	Measurement 789 793	TBUT
T30	Line 750 788	Serious tear film dysfunction syndrome
T31	Value 794 799	< 5 s
T32	Measurement 800 808	Schirmer
T33	Value 810 816	< 4 mm
T34	Measurement 817 821	OSDI
T35	Value 822 832	> 30 pints
T36	Measurement 833 849	Corneal staining
T37	Value 850 861	> grade III
T38	Qualifier 869 881	Oxford scale
T39	Line 789 799	TBUT < 5 s
T40	Line 800 816	Schirmer: < 4 mm
T41	Line 817 832	OSDI > 30 pints
T42	Line 833 881	Corneal staining > grade III on the Oxford scale
T43	Qualifier 883 897	Non perforated
T44	Condition 898 911	corneal ulcer
T45	Condition 924 937	corneal ulcer
T46	Qualifier 913 923	Perforated
T47	Condition 950 963	corneal ulcer
T48	Qualifier 939 949	Autoimmune
T49	Condition 965 997	Ocular surface scarring diseases
T50	Condition 1037 1044;999 1013	lesions Ocular surface
T51	Condition 1017 1044;999 1005	annexes metaplastic lesions Ocular
T52	Condition 1046 1082	Fibro vascular proliferation lesions
T53	Qualifier 1110 1125	corneal surface
T54	Qualifier 1090 1102	conjunctival
T55	Qualifier 1133 1142	pterygium
T57	Temporal 1145 1156	Concomitant
T58	Condition 1157 1186	chronic inflammatory diseases
T59	Qualifier 1194 1210	ocular structure
T60	Condition 1232 1252	inflammatory disease
T61	Qualifier 1212 1217	Acute
T62	Qualifier 1221 1231	infectious
T64	Condition 1254 1269	Corneal disease
T65	Procedure 1294 1303	treatment
T66	Mood 1270 1291	potentially requiring
T67	Temporal 1304 1333	during the following 3 months
T68	Non-representable 1335 1399	Use of topical or systemic drug products classified as forbidden
T69	Procedure 1401 1427	Ocular surgical procedures
T70	Temporal 1428 1467	3 months before the protocol inclusion
T71	Reference_point 1448 1466	protocol inclusion
T72	Temporal 1428 1466	3 months before the protocol inclusion
T73	Procedure 1468 1478	Treatments
T74	Procedure 1482 1492	procedures
T75	Procedure 1510 1541	tear film dysfunction treatment
T76	Device 1546 1568	punctal silicone plugs
T78	Condition 1571 1597	Posterior segment diseases
T79	Procedure 1610 1619	treatment
T80	Condition 1623 1655	threatening the visual prognosis
T81	Mood 1598 1607	requiring
T83	Device 1783 1802	hard contact lenses
T84	Procedure 1748 1772	penetrating keratoplasty
T85	Temporal 1706 1735	during the following 3 months
T86	Procedure 1696 1705	treatment
T87	Mood 1686 1695	requiring
T88	Condition 1657 1673	Retinal diseases
T89	Temporal 1737 1744	History
T90	Device 1775 1779;1788 1802	Soft contact lenses
T91	Temporal 1807 1847	during the last month from inclusion day
T92	Reference_point 1834 1847	inclusion day
